# EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT

> **NCT07748091** · — · RECRUITING · sponsor: **Istanbul University - Cerrahpasa** · enrollment: 62 (estimated)

## Conditions studied

- Major Depression Moderate
- Major Depression Severe
- Major Depression With Comorbid Anxiety Symptoms
- Major Depression With Panic Attacks
- Major Depression With Psychotic Features
- Major Depressive Episode
- Major Depressive Disorder (MDD
- Major Depression

## Interventions

- **DEVICE:** Electroconvulsive Therapy

## Key facts

- **NCT ID:** NCT07748091
- **Lead sponsor:** Istanbul University - Cerrahpasa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748091, "EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07748091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
